Get the Stockscreener App
10.20
14.00%
-1.66
Artelo Biosciences Inc stock is traded at $10.20, with a volume of 611.86K.
It is down -14.00% in the last 24 hours and up +7.37% over the past month.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
See More
Previous Close:
$11.86
Open:
$12
24h Volume:
611.86K
Relative Volume:
1.01
Market Cap:
$7.19M
Revenue:
-
Net Income/Loss:
$-9.60M
P/E Ratio:
-3.2278
EPS:
-3.16
Net Cash Flow:
$-8.96M
1W Performance:
-25.71%
1M Performance:
+7.37%
6M Performance:
+41.67%
1Y Performance:
+25.93%
1-Day Range:
$9.83
$12.16
1-Week Range:
$9.83
$14.14
52-Week Range:
$4.9176
$28.60
Artelo Biosciences Inc Stock (ARTL) Company Profile
Name
Artelo Biosciences Inc
Sector
Industry
Phone
858-925-7049
Address
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Compare ARTL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
10.20 | 8.31M | 0 | -9.60M | -8.96M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-25 | Upgrade | D. Boral Capital | Hold → Buy |
| Feb-12-21 | Initiated | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc Stock (ARTL) Latest News
Is it the right time to buy Artelo Biosciences Inc. stockAI Powered Updates From AI Tools - jammulinksnews.com
Why Artelo Biosciences Inc. is moving todayFree Low Capital High Return Stock Plans - Newser
Can technical indicators confirm Artelo Biosciences Inc.’s reversalFree Secure Return Focused Investment Plan - Newser
Can Artelo Biosciences Inc. recover in the next quarterPortfolio Safety Metrics and Return Analysis - Newser
Does Artelo Biosciences Inc. stock perform well during market downturnsEntry Signal Tracker With Proven Results - jammulinksnews.com
How strong is Artelo Biosciences Inc. company’s balance sheetFinancial News Updates For Consistent Profits - jammulinksnews.com
Artelo Biosciences Receives Favorable UK MHRA Guidance for a Pha - GuruFocus
Artelo Biosciences stock surges after receiving favorable UK regulatory guidance - Investing.com Canada
Novel CBD-Based Depression Treatment Outperforms Zoloft in Early Tests, UK Fast-Tracks Development - Stock Titan
Predicting Artelo Biosciences Inc. trend using moving averagesBuy Zone Strategy with Pattern Recognition - Newser
Will Artelo Biosciences Inc. rebound enough to break evenTrend Reversal Probability Forecast Update - Newser
Is Artelo Biosciences Inc. a Top Dividend Stock to Watch in 2025Free Short Term Trading Opportunity Watch - Newser
Combining price and volume data for Artelo Biosciences Inc.Free Daily Smart Money Movement Monitor - Newser
What makes Artelo Biosciences Inc. stock price move sharplyTrade Safety Matrix for Conservative Traders - Newser
What institutional flow reveals about Artelo Biosciences Inc.Alpha Stock Picks with Chart Confirmation - Newser
Artelo Biosciences (NASDAQ:ARTL) Stock Price Up 0.8% – Should You Buy? - Defense World
Using RSI to spot recovery in Artelo Biosciences Inc.Free Step-by-Step Trade Signal Implementation - Newser
What the charts say about Artelo Biosciences Inc. todayPortfolio Building Plan and Summary Guide - Newser
Sectors Driving Future Growth for Artelo Biosciences Inc. StockFree Growth Focused Entry Plan Suggestions - Newser
How many analysts rate Artelo Biosciences Inc. as a “Buy”Chart Pattern Updates With High Returns - jammulinksnews.com
Wyckoff Accumulation Phase Possible in Artelo Biosciences Inc.Real Time Alerts Based on AI Prediction Triggered - metal.it
What catalysts could drive Artelo Biosciences Inc. stock higher in 2025Stock Market Ideas With Proven Results - jammulinksnews.com
What are the latest earnings results for Artelo Biosciences Inc.Build a portfolio that outperforms the market - jammulinksnews.com
Why is Artelo Biosciences Inc. stock attracting strong analyst attentionUnmatched market gains - jammulinksnews.com
How does Artelo Biosciences Inc. generate profit in a changing economyOutstanding capital appreciation - jammulinksnews.com
Is Artelo Biosciences Inc. a growth stock or a value stockInvest confidently with professional market insights - jammulinksnews.com
What are analysts’ price targets for Artelo Biosciences Inc. in the next 12 monthsDiscover stocks with explosive potential - jammulinksnews.com
How volatile is Artelo Biosciences Inc. stock compared to the marketRealize exceptional returns through smart trading - jammulinksnews.com
Artelo Biosciences Inc. Company’s Quarterly Earnings Growth: What the Numbers SayElite Stock Shortlist - Newser
Is Artelo Biosciences Inc. a good long term investmentLightning-fast capital gains - PrintWeekIndia
What analysts say about Artelo Biosciences Inc. stockSky-high profits - PrintWeekIndia
How Artelo Biosciences Inc. stock performs during market volatility5x Profit Potential - Newser
Artelo Biosciences Inc Stock (ARTL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):